PepDiana
Back to Evidence
Primary experimental recordPositive observation

PMC12207141::ACT019623

LCKLSL

Evidence text

Paper-level observation

Figure 5K: The LDH release experiment showed that the treatments of matrine, PY60, and hexapeptide enhanced the killing of human CD8+ T cells on human Huh7 cells.
figureConfidence: medium

Assay observation

Activity
Anticancer
Subtype
Cytotoxic
Measure
percent_inhibition
Comparator
=
Raw observation
enhanced
Normalized measurement
=0
Value minimum
Not reported by source
Value maximum
Not reported by source
Target
Homo sapiens
Assay method
Not reported by source
Sequence
LCKLSL
Standardization
ready simple

Source publication

Targeting Annexin A2 to reactivate tumor-associated antigens presentation and relieve immune tolerance in liver cancer.

Journal for Immunotherapy of Cancer · 2025

DOI 10.1136/jitc-2025-011716 PMC12207141
Parent mention

Related peptide identities

PEPDIA-PLP-001707

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.